In vitiligo, hypopigmented or depigmented areas of skin occur as a result of an autoimmune disorder. The results of a large international survey confirm that vitiligo sufferers sometimes experience considerable distress. The therapeutic options have expanded in recent years. This applies in particular to the most common subtype, namely non-segmental vitiligo.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Case study
Orofacial Manifestations of Phelan-McDermid Syndrome
- Atherosclerotic Coronary Plaques in High-Risk Patients
Who benefits from preventive PCI?
- Colorectal Cancer
Insulin Resistance, Obesity, and Progression
- Modern asthma therapies
New data on biologics and triple therapy
- From symptom to diagnosis
Abdominal Pain – Focal Nodular Hyperplasia
- Clinically Suspected Arthralgias
“Watchful waiting” or intervention?
- Hepatology and Metabolism
The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?